TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28435128

Group type: EXPERIMENTAL
Intervention: Fast-track protocol (no preoperative bowel preparation, early restoration of diet, no postoperative antibiotics, early postoperative mobilization)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Fast-track protocol
Number of subjects: 227
Study: 26228031

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 901

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 901
Study: 24354899

Group type: EXPERIMENTAL
Intervention: Guided Self-Determination-Young (GSD-Y) intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard insulin pump training
Number of subjects: 80
Study: 21236502

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program (walking) for 8 weeks
Number of subjects: 0
Study: 19803727

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV-7)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No vaccination (control group)
Number of subjects: 98
Study: 17112807

Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg/d for 8 days)
Number of subjects: 8
Study: 15098972

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide 0.01% in combination with tretinoin and hydroquinone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical dexamethasone as monotherapy
Number of subjects: 0
Study: 11739811

Group type: EXPERIMENTAL
Intervention: IFNbeta-1b
Number of subjects: 718

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 718
Study: 9010146

Group type: EXPERIMENTAL
Intervention: MGDF (0.03, 0.1, 0.3, 1.0, 3.0, or 5.0 microg/kg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: MGDF
Number of subjects: 53
Study: 8116312

Group type: EXPERIMENTAL
Intervention: Polychemotherapy regimen with a platinum dose intensity of 8 mg/m2/week
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Polychemotherapy regimen with a platinum dose intensity of 18 mg/m2/week
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Carboplatinum and cisplatinum with a planned dose intensity of 43.75 mg/m2/week
Number of subjects: 294

Group type: COMPARATOR
Intervention: Standard polychemotherapy (cyclophosphamide/cisplatinum) with a planned dose intensity of 25 mg/m2/week
Number of subjects: 294
Study: 3687358

Group type: EXPERIMENTAL
Intervention: Sitting for 2, 10, 15, 20, or 25 minutes before transitioning to horizontal supine position
Number of subjects: 50
Study: 29909708

Group type: COMPARATOR
Intervention: Standard prophylactic mode (thrombopoietin, 15,000 units/day on days 2–11)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pre-chemo mode (thrombopoietin, 15,000 units/day on days -4, -2, and 2–9)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard prophylactic mode
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pre-chemo mode
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both modes
Number of subjects: 52
Study: 27142805

Group type: EXPERIMENTAL
Intervention: Standardised confocal scanning laser indocyanine green angiography (ICGA)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Screening failures identified by imaging criteria
Number of subjects: 34
Study: 25002391

Group type: EXPERIMENTAL
Intervention: Patients with blood pressure ≥ 140/90 mm Hg (experiment group)
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Patients with blood pressure <140/90 mm Hg (control group)
Number of subjects: 1141
Study: 22699083

Group type: EXPERIMENTAL
Intervention: Mechanical anastomosis (stapler)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Manual anastomosis
Number of subjects: 227
Study: 20525031

Group type: EXPERIMENTAL
Intervention: Behavioral treatments for co-occurring SUD and PTSD (specifics not provided)
Number of subjects: 122
Study: 18721084

Group type: EXPERIMENTAL
Intervention: T'ai chi chuan (TCC) training for 12 months
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual-care (sedentary lifestyle)
Number of subjects: 53
Study: 15972378

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (platinum-based regimens)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (specific regimens not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no adjuvant chemotherapy)
Number of subjects: 0
Study: 12904519

Group type: EXPERIMENTAL
Intervention: Sentinel-node biopsy followed by axillary dissection only if the sentinel node contained metastases (sentinel-node group)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Sentinel-node biopsy and total axillary dissection (axillary-dissection group)
Number of subjects: 516
Study: 10505538

Group type: EXPERIMENTAL
Intervention: Medium-dose hirudin
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Low-dose hirudin
Number of subjects: 909

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Moderate-intensity warfarin (INR 2-2.5)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Standard therapy (aspirin alone)
Number of subjects: 909
Study: 8525777

Group type: EXPERIMENTAL
Intervention: Subunit influenza vaccine (15 micrograms of each haemagglutinin strain)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not vaccinated)
Number of subjects: 51
Study: 1751342

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 248

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 248
Study: 7034773

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated eyes (Control)
Number of subjects: 0
Study: 30994376

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss (BWL) intervention
Number of subjects: 26

Group type: COMPARATOR
Intervention: Recommended care (RC)
Number of subjects: 26
Study: 28528578

Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention targeting health professionals
Number of subjects: 88000

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 88000
Study: 28024715

Group type: COMPARATOR
Intervention: Standard anesthesia with thiopentone for induction and maintenance with isoflurane-fentanyl (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol for induction and maintenance along with fentanyl (Group B)
Number of subjects: 60
Study: 25053514

Group type: COMPARATOR
Intervention: Single energy computed tomography (SECT) with full iodine volume load (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dual-energy computed tomography (DECT) with 50% iodine volume load (group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dual-energy computed tomography (DECT) with 40% iodine volume load (group C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dual-energy computed tomography (DECT) with 30% iodine volume load (group D)
Number of subjects: 80
Study: 22461416

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 9251

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d
Number of subjects: 9251

Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 9251

Group type: EXPERIMENTAL
Intervention: Baseline apolipoprotein A-I
Number of subjects: 9251
Study: 19721120

Group type: EXPERIMENTAL
Intervention: Imaginal desensitisation plus motivational interviewing (IDMI)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Gamblers Anonymous (Control)
Number of subjects: 68
Study: 17855054

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no PRP)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: PRP treatment
Number of subjects: 11
Study: 15209305

Group type: EXPERIMENTAL
Intervention: Peripheral vision practice
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Central vision practice
Number of subjects: 16
Study: 11590456

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 9782034

Group type: EXPERIMENTAL
Intervention: Preservation of the intercostobrachial nerve (ICBN)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Division of the intercostobrachial nerve (ICBN)
Number of subjects: 120
Study: 7875838

Group type: EXPERIMENTAL
Intervention: WHO suggested culture appropriate psychosocial Basic Test Battery
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Nutritional assessment using Jellife's technique
Number of subjects: 600
Study: 3168311

Group type: EXPERIMENTAL
Intervention: Methimazole (MMI, 40 mg/day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Methimazole + Sodium Ipodate (MMI + Na Ipodate, 1 g/day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Methimazole + Saturated Solution of Potassium Iodide (MMI + SSKI, 6 drops twice daily)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 7
Study: 31520301

Group type: EXPERIMENTAL
Intervention: Behavioural weight management intervention
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 221
Study: 29723029

Group type: EXPERIMENTAL
Intervention: Polyvictimization profile
Number of subjects: 2776

Group type: EXPERIMENTAL
Intervention: Witnessing profile
Number of subjects: 2776

Group type: EXPERIMENTAL
Intervention: Low victimization profile
Number of subjects: 2776
Study: 28338191

Group type: EXPERIMENTAL
Intervention: Lidocaine spray 10 g/100 ml at 5 min before intercourse (G1)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily (G2)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Tadalafil once daily plus lidocaine spray before planned sexual activity (G3)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Lidocaine spray (G1)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Tadalafil (G2)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Tadalafil plus lidocaine spray (G3)
Number of subjects: 78
Study: 25413592

Group type: EXPERIMENTAL
Intervention: LFQS + IPL
Number of subjects: 20

Group type: COMPARATOR
Intervention: LFQS
Number of subjects: 20
Study: 23375825

Group type: EXPERIMENTAL
Intervention: Lights Plus (immediate feedback to teens plus family access to event videos and ranking)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lights Only (immediate feedback to teens)
Number of subjects: 90
Study: 20636232

Group type: EXPERIMENTAL
Intervention: Polycystic ovary syndrome (PCOS) group
Number of subjects: 366

Group type: COMPARATOR
Intervention: Control group (tubal factor)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Both groups (PCOS and control)
Number of subjects: 366
Study: 19273708

Group type: EXPERIMENTAL
Intervention: Edrecolomab (ED) plus fluorouracil (FU) based therapy
Number of subjects: 1839

Group type: COMPARATOR
Intervention: Fluorouracil (FU) based therapy alone
Number of subjects: 1839
Study: 17363845

Group type: EXPERIMENTAL
Intervention: rosuvastatin 5-40 mg
Number of subjects: 16876

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16876

Group type: EXPERIMENTAL
Intervention: rosuvastatin < or = 20 mg
Number of subjects: 16876

Group type: EXPERIMENTAL
Intervention: rosuvastatin
Number of subjects: 16876

Group type: EXPERIMENTAL
Intervention: rosuvastatin < or = 40 mg
Number of subjects: 16876
Study: 15543084

Group type: EXPERIMENTAL
Intervention: 0.4% copper oxide ointment
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 20% elementary copper ointment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 61
Study: 14675923

Group type: EXPERIMENTAL
Intervention: ILC
Number of subjects: 31

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 31
Study: 9647551

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 25 mg/day plus testosterone enanthate (TE) 100 mg/week
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 12.5 mg/day plus testosterone enanthate (TE) 100 mg/week
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control phase (not specified)
Number of subjects: 10
Study: 8086694

Group type: EXPERIMENTAL
Intervention: Oral IgA‐IgG
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral Gentamicin
Number of subjects: 200
Study: 2722974

Group type: EXPERIMENTAL
Intervention: Brand A ranitidine tablets
Number of subjects: 10

Group type: COMPARATOR
Intervention: Brand B ranitidine tablets
Number of subjects: 10
Study: 9292

Group type: EXPERIMENTAL
Intervention: Alprenolol 600 mg daily in divided doses for six weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo therapy for six weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 16
Study: 31549424

Group type: EXPERIMENTAL
Intervention: All-on-4 rehabilitation in the maxilla using at least two Zygoma implants (group 2)
Number of subjects: 70

Group type: COMPARATOR
Intervention: All-on-4 rehabilitation in the maxilla (group 1)
Number of subjects: 70

Group type: COMPARATOR
Intervention: All-on-4 rehabilitation in the mandible (group 3)
Number of subjects: 70
Study: 31431779

Group type: COMPARATOR
Intervention: Aerobic interval training (AIT)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Resistance interval training plus aerobic interval training (AIT)
Number of subjects: 26
Study: 25905646

Group type: EXPERIMENTAL
Intervention: Memory strategy training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive working memory practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 0
Study: 25656375

Group type: EXPERIMENTAL
Intervention: Group M+R (5ml solution containing 0.25% ropivacaine plus 5mg/kg magnesium sulphate)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Group R (5ml 0.25% ropivacaine)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Group M (5ml solution containing 5mg/kg magnesium sulphate)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Group M+R
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Group R
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Group M+R and Group R
Number of subjects: 61
Study: 22933120

Group type: EXPERIMENTAL
Intervention: Intra-operative hydrotubation (IH)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Post-operative hydrotubation (PH)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 21556447

Group type: EXPERIMENTAL
Intervention: Intramuscular methyl prednisolone (40 mg) administered at two-week intervals, starting at the time of the procedure.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual preventive measures only (control group).
Number of subjects: 200
Study: 19465192

Group type: EXPERIMENTAL
Intervention: Whey protein concentrate (Resource Beneprotein Instant Protein Powder)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fortified collagen protein hydrolysate (Pro‐Stat 101)
Number of subjects: 9
Study: 17804844

Group type: EXPERIMENTAL
Intervention: Dual-chamber minimal ventricular pacing
Number of subjects: 1065

Group type: COMPARATOR
Intervention: Conventional dual-chamber pacing
Number of subjects: 1065
Study: 14998794

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11703562

Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin at 18:00 hr
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin at 20:00 hr
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1.0 mg melatonin at 21:00 hr
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin
Number of subjects: 6
Study: 9502357

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Structured exercise prescription
Number of subjects: 235
Study: 7983648

Group type: EXPERIMENTAL
Intervention: SLE Disease Activity Index (SLEDAI)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Systemic Lupus Activity Measure (SLAM)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: British Isles Lupus Assessment Group (BILAG)
Number of subjects: 8
Study: 2596428

Group type: EXPERIMENTAL
Intervention: Canola oil (CO) diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunflower oil (SO) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixture of fats (MF) diet
Number of subjects: 0
Study: 4080

Group type: EXPERIMENTAL
Intervention: Metoprolol 20 mg t.d.s.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg t.d.s.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31740724

Group type: EXPERIMENTAL
Intervention: Occupants with obesity
Number of subjects: 13470
Study: 30932957

Group type: EXPERIMENTAL
Intervention: Facilities offering provider training in adolescent-friendly care
Number of subjects: 3662

Group type: EXPERIMENTAL
Intervention: Facilities using the Kenyan government's AYA care checklist
Number of subjects: 3662

Group type: EXPERIMENTAL
Intervention: Facilities where providers reported being trained in AYA HIV care
Number of subjects: 3662
Study: 28242873

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (60 IU)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (8.7% sodium chloride)
Number of subjects: 37
Study: 26493435

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (MOX) therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 40
Study: 23775371

Group type: EXPERIMENTAL
Intervention: Social networking recruitment approach
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Telephone screening
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Health assessment screening
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Recruitment process
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Provision of health assessment screening
Number of subjects: 609
Study: 22117123

Group type: EXPERIMENTAL
Intervention: Computerized stress management intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 60
Study: 19395710

Group type: EXPERIMENTAL
Intervention: Quality improvement educational program
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 16984588

Group type: EXPERIMENTAL
Intervention: Preoperative proton pump inhibitor (PPI) administration for 1 week before EMR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endoscopic mucosal resection (EMR) without preoperative PPI administration
Number of subjects: 0
Study: 16874155

Group type: EXPERIMENTAL
Intervention: Exercise training programme (Group A)
Number of subjects: 44
Study: 12969092

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Lansoprazole
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Rabeprazole
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Esomeprazole
Number of subjects: 1085
Study: 10354241

Group type: EXPERIMENTAL
Intervention: Training and structured assessment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 39
Study: 7854524

Group type: EXPERIMENTAL
Intervention: Clinical AIDS group (n = 52)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: CD4+ < 200/mm3 group (n = 57)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Dementia group (n = 29)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Sensory neuropathy
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 138
Study: 1742526

Group type: EXPERIMENTAL
Intervention: Tissucol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 7037868

Group type: EXPERIMENTAL
Intervention: Zomepirac sodium, 100 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxycodone with APC (Percodan)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29287669

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to neoadjuvant carboplatin‐paclitaxel chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neoadjuvant carboplatin‐paclitaxel chemotherapy without bevacizumab (implied control)
Number of subjects: 0
Study: 30641618

Group type: EXPERIMENTAL
Intervention: Fangshuan Capsule (FC), 6 pills each time, three times per day for at least 2 days before PCI operation, therapeutic course of 2 weeks.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fangshuan Capsule (FC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (routine Western medicine therapy only)
Number of subjects: 100
Study: 25672179

Group type: EXPERIMENTAL
Intervention: Partial nail avulsion with application of phenol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Partial nail avulsion alone
Number of subjects: 100
Study: 24352000

Group type: EXPERIMENTAL
Intervention: Multicultural education program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 20438782

Group type: EXPERIMENTAL
Intervention: 25cL white wine (750kJ; approximately 26g alcohol)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cake (750kJ)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 25cL water
Number of subjects: 22
Study: 18801111

Group type: EXPERIMENTAL
Intervention: 3.0 g/day maca
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.5 g/day maca
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maca (both doses)
Number of subjects: 20
Study: 16936236

Group type: EXPERIMENTAL
Intervention: Theophylline (400 mg/day orally)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) (400 mug/day inhalation)
Number of subjects: 16
Study: 12969101

Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural analgesia (EDA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuous intercostal (IC) block
Number of subjects: 50
Study: 10939786

Group type: EXPERIMENTAL
Intervention: Perindopril treatment for blood pressure reduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 8967704

Group type: EXPERIMENTAL
Intervention: LDL apheresis plus simvastatin, 40 mg/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: Simvastatin, 40 mg/d
Number of subjects: 42
Study: 1548923

Group type: EXPERIMENTAL
Intervention: Heparin-coated equipment with low systemic heparinization (heparin 5000 IU) during left heart bypass or partial cardiopulmonary bypass
Number of subjects: 47

Group type: COMPARATOR
Intervention: Low systemic heparinization (activated clotting time > 180 seconds)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: No systemic heparinization during cardiopulmonary bypass
Number of subjects: 47